Bharat Biotech's cholera vaccine successfully completes Phase-III trialsBharat Biotech's oral Cholera Vaccine, Hillchol, has successfully completed phase III clinical trials, demonstrating non-inferiority agains...
Bharat Biotech launches oral cholera vaccine Hillchol after positive phase 3 trialBharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high globa...
New cholera vaccine in clinical stage promises to end supply shortageCholera is an acute diarrheal infection caused by food or water carrying the vibrio cholerae bacteria.